Detalles de la búsqueda
1.
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
N Engl J Med
; 386(1): 11-23, 2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34986284
2.
Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
Br J Haematol
; 204(3): 892-897, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38013238
3.
Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasms.
Br J Haematol
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38639421
4.
DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study.
Br J Haematol
; 204(5): 1838-1843, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38471524
5.
A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study).
Ann Hematol
; 103(3): 705-713, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175253
6.
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis.
Am J Hematol
; 99(4): 755-758, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291566
7.
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
Cancer
; 128(13): 2441-2448, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417564
8.
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.
Br J Haematol
; 199(4): 529-538, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36089912
9.
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.
Blood
; 136(16): 1851-1862, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573691
10.
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations.
Br J Haematol
; 194(4): 708-717, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34296432
11.
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients.
Ann Hematol
; 100(8): 1995-2004, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33409621
12.
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model.
Biol Blood Marrow Transplant
; 26(12): 2237-2244, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717433
13.
SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria.
Haematologica
; 109(1): 283-286, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584297
14.
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
Am J Hematol
; 92(7): 614-621, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370234
15.
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.
Am J Hematol
; 92(9): E534-E541, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28612357
16.
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
Mod Pathol
; 29(12): 1541-1551, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27562492
17.
Highly variable mutational profile of ASXL1 in myelofibrosis.
Eur J Haematol
; 97(4): 331-5, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26714837
18.
Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia.
Eur J Haematol
; 97(1): 33-8, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341961
19.
Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases.
Am J Hematol
; 91(2): 185-92, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26509444
20.
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
Cancer
; 121(3): 423-31, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25251326